Press Releases
Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 | PRLog
Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019. Laryngeal Cancer Therapeutics Market is Forecast to Show Slow Growth Until 2019 - PR11793534
American Society of Retina Specialists Publishes Compounding Pharmacy Information to Promote Safety
Responding to recent incidents of blinding endophthalmitis after injections of Avastin, the American Society of Retina Specialists is publishing safety information for physicians on the compounding pharmacies that prepare the drug for injection into the eye.
Medical News: CT Morphology Stratifies Colorectal Liver Metastases - in Hematology/Oncology, Colon
Computed tomography (CT) assessment of morphologic changes accurately stratified patients with colorectal liver metastases according to quality of response to bevacizumab (Avastin)-based systemic ther
New Treatment Protocol at Westchester Brain Tumor Program Offers a Ray of Hope for Deadly Cancer |
New Treatment Protocol at Westchester Brain Tumor Program Offers a Ray of Hope for Deadly Cancer. A Powerful Drug Is Now Applied Directly to the GBM Brain Tumor Site - PR11750761
AREVA Med Initiates Phase 1 Clinical Trial of ²¹²Pb-TCMC-Trastuzumab in Patients with HER-2
AREVA announced that its subsidiary AREVA Med has started a Phase 1 clinical trial for its lead product ²¹²Pb-TCMC-Trastuzumab in patients with HER-2 positive intra-abdominal cancers.
PromosLogos Supports Broadening of Drug and Treatment Options for Breast Cancer and Helps Raise
Breast cancer affects thousands of families each year, so it's imperative that proper drug and treatment options are made available to these patients. PromosLogos gets involved with this particular health issue by keeping tabs on recent developments and by donating part of their sales to breast
“Cure” Author Comments on the FDA and The Avastin Story | PRLog
“Cure” Author Comments on the FDA and The Avastin Story. The Cure, published in 2009, discusses the perils of fast-tracking breast cancer drugs for approval and the consequences for women with metastatic breast cancer. - PR11568154
Market Report, "Gastric Cancer Drug Discoveries: What the Future Holds", published | PRLog
Market Report, "Gastric Cancer Drug Discoveries: What the Future Holds", published. Fast Market Research recommends "Gastric Cancer Drug Discoveries: What the Future Holds" from Espicom Business Intelligence, now available - PR11537073
Cancer Drug Expansion Approves by Ontario
Cancer Drug Expansion Approves by Ontario. The Ontario government announced Monday its intention to expand access to cancer drugs for patients who can benefit from the drug, but that does not meet the strict clinical guidelines for use. - PR11389068
Global Angiogenesis Inhibitors and Stimulators Market to Reach US$53.5 Billion by 2015, According
GIA announces the release of a comprehensive global report on Angiogenesis Inhibitors and Stimulators markets. The global market for Angiogenesis Inhibitors and Stimulators is forecast to reach US$53.5 billion by the year 2015. Aging population worldwide, increasing incidence of cancer patients and
Refine by Content Type:
Refine by Source:
- www.prlog.org (9)
- www.prweb.com (4)
- www.medpagetoday.com (2)
